Cerevel Therapeutics Holdings, Inc.
CERE · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$433 | -$352 | -$225 | -$152 |
| Dep. & Amort. | $6 | $5 | $3 | $0 |
| Deferred Tax | -$2 | $0 | $4 | $3 |
| Stock-Based Comp. | $69 | $39 | $24 | $11 |
| Change in WC | $16 | $28 | $16 | $18 |
| Other Non-Cash | $1 | -$13 | $1 | $2 |
| Operating Cash Flow | -$342 | -$293 | -$179 | -$118 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$4 | -$11 | -$19 |
| Net Acquisitions | -$0 | $0 | $0 | $0 |
| Inv. Purchases | -$865 | -$888 | -$425 | $0 |
| Inv. Sales/Matur. | $943 | $503 | $0 | $0 |
| Other Inv. Act. | $0 | -$0 | -$0 | $0 |
| Investing Cash Flow | $74 | -$389 | -$436 | -$19 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $518 | $251 | $328 | $6 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $549 | $623 | $424 | $441 |
| Financing Cash Flow | $549 | $623 | $424 | $441 |
| Forex Effect | $549 | $0 | $0 | $0 |
| Net Chg. in Cash | $99 | -$59 | -$191 | $304 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $892 | $197 | $388 | $84 |
| End Cash | $991 | $138 | $197 | $388 |
| Free Cash Flow | -$346 | -$297 | -$189 | -$137 |